Two Sigma Investments’s Sionna Therapeutics SION Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$75.2K Buy
+14,300
New +$328K ﹤0.01% 4721
2026
Q2
– Sell
-5,500
Closed -$220K – 5533
2026
Q1
$220K Sell
5,500
-900
-14% -$34.3K ﹤0.01% 4246
2025
Q4
$263K Buy
+6,400
New +$243K ﹤0.01% 3640
2025
Q2
– Sell
-11,715
Closed -$123K – 3645
2025
Q1
$123K Buy
+11,715
New +$191K ﹤0.01% 2939

Other funds holding SION

Two Sigma Investments's SION Position: Q3 2026 in Review

Two Sigma Investments opened a new position in Sionna Therapeutics (SION) in Q3 2026: 14,300 shares worth $75.2K. The stake represents ﹤0.01% of the portfolio and ranks #4721 among its holdings. This is a return to the name: Two Sigma Investments previously reported a position in SION as recently as Q1 2026.

Two Sigma Investments first reported a position in SION in Q1 2025 and has held it in 4 quarters since. The position peaked at $263K in Q4 2025. 129 funds tracked by Wall St. Rank hold SION as of Q3 2026.

  • Two Sigma Investments held 14,300 shares of Sionna Therapeutics worth $75.2K as of Q3 2026.
  • Sionna Therapeutics was a new Two Sigma Investments position in Q3 2026.
  • Sionna Therapeutics made up ﹤0.01% of Two Sigma Investments's portfolio in Q3 2026, its #4721 holding.
  • Two Sigma Investments first reported a position in Sionna Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • Two Sigma Investments's Sionna Therapeutics position peaked at $263K in Q4 2025.
  • 129 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q3 2026.

Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.